Search Results 281-290 of 16123 for immunothérapie Bylaska
The purpose of this study is to evaluate the long-term safety in patients previously treated with Medeor cellular immunotherapy products in a Medeor parent ...
Participation eligibility · Prior exposure to any chemotherapy, PARPi, or immunotherapy for prostate cancer. · Pure Small Cell Carcinoma. · Prior abiraterone, ...
No treatment with chemotherapy, radiation therapy, immunotherapy, biological therapy, hormonal therapy, or other thiazolidinediones (TZDs) =< 21 days before ...
Contact Marion R. Curtis, Ph.D., about research training and education in immunotherapy for ovarian cancer in Mayo Clinic's Immunometabolism and Cancer ...
This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...
Bacillus Calmette-Guérin (BCG) is used as a solution that is run through a tube (instilled through a catheter) into the bladder to treat bladder cancer. The ...
The purpose of this study is to evaluate patient outcomes after undergoing 68Ga-PSMA PET/CT imaging prior to initiation of immunotherapy to identify PSMA ...
Medical Departments & Centers · Mayo Clinic Comprehensive Cancer Center · cancer-care; find-cancer-clinical-trials. Final days of 5X Challenge!
Immunotherapy ≤ 28 days prior to registration; Biologic therapy ≤ 28 days ... Other concurrent chemotherapy, immunotherapy, radiotherapy, or any ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.